124 related articles for article (PubMed ID: 19055859)
1. Thrombomodulin and GFC levels in Legg-Calve-Perthes disease.
Aksoy MC; Aksoy DY; Haznedaroglu IC; Sayinalp N; Kirazli S; Alpaslan M
Hematology; 2008 Dec; 13(6):324-8. PubMed ID: 19055859
[TBL] [Abstract][Full Text] [Related]
2. Increased soluble selectins as a reflection of activated platelets and endothelium in Legg-Calve-Perthes disease.
Ismayilov V; Aksoy DY; Sayinalp N; Haznedaroğlu IC; Aksoy MC
J Pediatr Hematol Oncol; 2014 Oct; 36(7):e410-1. PubMed ID: 25000467
[TBL] [Abstract][Full Text] [Related]
3. Enhanced tissue factor pathway inhibitor response as a defense mechanism against ongoing local microvascular events of Legg-Calve-Perthes disease.
Aksoy MC; Aksoy DY; Haznedaroglu IC; Sayinalp N; Kirazli S; Alpaslan M
Pediatr Hematol Oncol; 2005; 22(5):391-9. PubMed ID: 16020129
[TBL] [Abstract][Full Text] [Related]
4. Role of leptin in Legg-Calvé-Perthes disease.
Lee JH; Zhou L; Kwon KS; Lee D; Park BH; Kim JR
J Orthop Res; 2013 Oct; 31(10):1605-10. PubMed ID: 23832827
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics in Legg-Calvé-Perthes disease: A study of global DNA methylation.
Zheng P; Yang T; Ju L; Jiang B; Lou Y
J Int Med Res; 2015 Dec; 43(6):758-64. PubMed ID: 26443715
[TBL] [Abstract][Full Text] [Related]
6. Coagulation abnormalities in Legg-Calvé-Perthes disease.
Vosmaer A; Pereira RR; Koenderman JS; Rosendaal FR; Cannegieter SC
J Bone Joint Surg Am; 2010 Jan; 92(1):121-8. PubMed ID: 20048104
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil to lymphocyte ratio may be a predictive marker of poor prognosis in Legg-Calvé-Perthes disease.
Kaymaz B; Büyükdogan K; Kaymaz N; Kömürcü E; Golge UH; Goksel F; Aksoy MC
Hip Int; 2016 Nov; 26(6):598-601. PubMed ID: 27229163
[TBL] [Abstract][Full Text] [Related]
8. Alterations of serum osteocalcin levels in patients with Legg-Calvé-Perthes.
Wei WB; Dang SJ; Li Y; Liu ZZ
Hip Int; 2017 Feb; 27(1):92-95. PubMed ID: 27886352
[TBL] [Abstract][Full Text] [Related]
9. Is VEGF under-expressed in Indian children with Perthes disease?
Tiwari V; Poudel RR; Khan SA; Mehra S; Chauhan SS; Raje A
Musculoskelet Surg; 2018 Apr; 102(1):81-85. PubMed ID: 28956304
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of serum proteomes in Legg-Calve-Perthes disease.
Liu R; Fan L; Yin L; Wang K; Miao W; Song Q; Dang X; Gao H; Bai C
BMC Musculoskelet Disord; 2015 Oct; 16():281. PubMed ID: 26438379
[TBL] [Abstract][Full Text] [Related]
11. Legg-Calve-Perthes disease and risks for cardiovascular diseases and blood diseases.
Hailer YD; Montgomery SM; Ekbom A; Nilsson OS; Bahmanyar S
Pediatrics; 2010 Jun; 125(6):e1308-15. PubMed ID: 20439602
[TBL] [Abstract][Full Text] [Related]
12. [Delay in skeletal maturity in Mexican patients with Legg-Calvé-Perthes].
Nava Zarco NA; Mijares Morán J; Hernández MA
Acta Ortop Mex; 2008; 22(3):157-61. PubMed ID: 18826078
[TBL] [Abstract][Full Text] [Related]
13. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
Wu KK; Matijevic-Aleksic N
Ann Med; 2000 Dec; 32 Suppl 1():73-7. PubMed ID: 11209986
[TBL] [Abstract][Full Text] [Related]
14. [Legg-Calvé-Perthes disease].
Frías Austria R
Acta Ortop Mex; 2009; 23(3):172-81. PubMed ID: 19739354
[TBL] [Abstract][Full Text] [Related]
15. Legg-Calvé-Perthes disease and passive smoking.
García Mata S; Ardanaz Aicua E; Hidalgo Ovejero A; Martinez Grande M
J Pediatr Orthop; 2000; 20(3):326-30. PubMed ID: 10823599
[TBL] [Abstract][Full Text] [Related]
16. Computerized gait analysis in Legg Calvé Perthes disease--analysis of the frontal plane.
Westhoff B; Petermann A; Hirsch MA; Willers R; Krauspe R
Gait Posture; 2006 Oct; 24(2):196-202. PubMed ID: 16226031
[TBL] [Abstract][Full Text] [Related]
17. Protein C levels in patients with Legg-Calve-Perthes disease: is it a true deficiency?
Mehta JS; Conybeare ME; Hinves BL; Winter JB
J Pediatr Orthop; 2006; 26(2):200-3. PubMed ID: 16557135
[TBL] [Abstract][Full Text] [Related]
18. Comparison of bone age delay and recovery in Meyer dysplasia and Legg-Calvé-Perthes disease: a pilot study.
Sun XT; Easwar TR; Cielo B; Song SH; Kim SJ; Song HR
J Orthop Sci; 2010 Nov; 15(6):746-52. PubMed ID: 21116891
[TBL] [Abstract][Full Text] [Related]
19. Potential for bisphosphonate treatment in Legg-Calve-Perthes disease.
Little DG; Kim HK
J Pediatr Orthop; 2011 Sep; 31(2 Suppl):S182-8. PubMed ID: 21857436
[TBL] [Abstract][Full Text] [Related]
20. Effects of circulating endothelial progenitor cells, serum vascular endothelial growth factor and hypogammaglobulinemia in Perthes disease.
Sezgin H; Gülman B; Çıraklı A; Bedir A; Usta D; Coşkun S; Yıldıran A
Acta Orthop Traumatol Turc; 2014; 48(6):628-34. PubMed ID: 25637726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
